Clinical Utility of Long-Acting Injectable Risperidone in Schizophrenia and Bipolar I Disorder: A Review of Clinical Studies
Francesco Bartoli, Daniele Cavaleri, Ilaria Riboldi, Chiara Alessandra Capogrosso, Giuseppe Carr&#x00E0School of Medicine and Surgery, University of Milano-Bicocca, Monza, 20900, ItalyCorrespondence: Daniele Cavaleri, School of Medicine and Surgery, University of Milano-Bicocca, via Cadore 4...
Saved in:
| Main Authors: | Bartoli F, Cavaleri D, Riboldi I, Capogrosso CA, Carrà G |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-06-01
|
| Series: | Psychology Research and Behavior Management |
| Subjects: | |
| Online Access: | https://www.dovepress.com/clinical-utility-of-long-acting-injectable-risperidone-in-schizophreni-peer-reviewed-fulltext-article-PRBM |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Evaluation of the Subcutaneous Depot Release of TV-46000, A Novel Long-Acting Injectable (LAI) Formulation of Risperidone, Under Extreme Conditions in Dogs, Minipigs and Humans
by: Lilach Steiner, et al.
Published: (2025-01-01) -
Population Pharmacokinetic Modeling of TV-46000, a Risperidone Long-Acting Subcutaneous Antipsychotic for the Treatment of Patients with Schizophrenia
by: Itay Perlstein, et al.
Published: (2025-03-01) -
The maintenance of modified electroconvulsive therapy combined with risperidone is better than risperidone alone in preventing relapse of schizophrenia and improving cognitive function
by: Ying Yang, et al. -
Risperidone-induced Myoclonus in a Young Patient with Schizophrenia
by: Aman Naqvi, et al.
Published: (2025-01-01) -
Activation of osteoblast ferroptosis by risperidone accelerates bone loss in mice models of schizophrenia
by: Hongyan Fan, et al.
Published: (2025-01-01)